These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33851153)
1. Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. Lubinski B; Fernandes MHV; Frazier L; Tang T; Daniel S; Diel DG; Jaimes JA; Whittaker GR bioRxiv; 2021 Nov; ():. PubMed ID: 33851153 [TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. Lubinski B; Fernandes MHV; Frazier L; Tang T; Daniel S; Diel DG; Jaimes JA; Whittaker GR iScience; 2022 Jan; 25(1):103589. PubMed ID: 34909610 [TBL] [Abstract][Full Text] [Related]
3. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants. Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299 [TBL] [Abstract][Full Text] [Related]
4. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance. Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154 [TBL] [Abstract][Full Text] [Related]
5. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda. Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497 [TBL] [Abstract][Full Text] [Related]
6. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Liu Y; Liu J; Johnson BA; Xia H; Ku Z; Schindewolf C; Widen SG; An Z; Weaver SC; Menachery VD; Xie X; Shi PY Cell Rep; 2022 May; 39(7):110829. PubMed ID: 35550680 [TBL] [Abstract][Full Text] [Related]
7. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin. Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808 [TBL] [Abstract][Full Text] [Related]
8. Intrinsic furin-mediated cleavability of the spike S1/S2 site from SARS-CoV-2 variant B.1.1.529 (Omicron). Lubinski B; Jaimes JA; Whittaker GR bioRxiv; 2022 Jul; ():. PubMed ID: 35923311 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner. Lavie M; Dubuisson J; Belouzard S J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602 [TBL] [Abstract][Full Text] [Related]
10. Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda. Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR bioRxiv; 2022 Mar; ():. PubMed ID: 34230931 [TBL] [Abstract][Full Text] [Related]
11. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain. Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289 [TBL] [Abstract][Full Text] [Related]
12. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil. Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G; Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783 [TBL] [Abstract][Full Text] [Related]
13. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease. Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein. Matveev EV; Ponomarev GV; Kazanov MD Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein. Arora P; Sidarovich A; Graichen L; Hörnich B; Hahn A; Hoffmann M; Pöhlmann S PLoS One; 2022; 17(3):e0265453. PubMed ID: 35333910 [TBL] [Abstract][Full Text] [Related]
19. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Liu Y; Liu J; Johnson BA; Xia H; Ku Z; Schindewolf C; Widen SG; An Z; Weaver SC; Menachery VD; Xie X; Shi PY bioRxiv; 2021 Sep; ():. PubMed ID: 34462752 [TBL] [Abstract][Full Text] [Related]
20. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site. Jaimes JA; Millet JK; Whittaker GR SSRN; 2020 May; ():3581359. PubMed ID: 32714113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]